A study to investigate the effect of food with mirabegron in healthy Chinese participants

Trial Identifier: 178-MA-2294
Sponsor: Astellas Pharma China, Inc.
Start Date: September 2020
Primary Completion Date: October 2020
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Shanghai, China